Metraipolis › archive › dc_afd7ee042dd1

Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42243346
DOI
10.1038/s41598-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-31T20:20:23.855Z
SHA-256 of the archived text
9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01
Stable URL of this page
https://metraipolis.com/documento/dc_afd7ee042dd1

How to cite

Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346 — Europe PMC (en), https://europepmc.org/article/MED/42243346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afd7ee042dd1 (Metraipolis archive dc_afd7ee042dd1, sha256 9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01)
BibTeX
@misc{dcafd7ee042dd1,
  title = {Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42243346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afd7ee042dd1; sha256 9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42243346. Agents can read the archived copy with the MCP tool read_document.